Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to proceed with the clinical development of BB2603 for the treatment of onychomycosis. The IND is a [...]
Drug discovery and development company Blueberry Therapeutics announced the appointment of Dr. Adrian Howd to its Board as an independent Non-Executive Director, strengthening its strategic, financial and therapeutic expertise. Dr. Howd has over 20 years’ experience in the life science sector. He has held various private and public company Executive and [...]
Written by Dr Heather Davies-Strickleton, Senior Analytical Scientist Now a new year is here we start to take a closer look at ourselves. Our body shape, weight and diet are key areas we frequently [...]
Written by Heather Davies-Strickleton, Senior Analytical Scientist Running into trouble: Athlete’s foot is a common problem Athlete’s foot needs no introduction. A whopping 1 in 6 of us are estimated to have this fungal infection [...]
Sports are a big part of our lives. The benefits of keeping active and healthy, both physically and mentally, have never been more recognised. However, sports also come with risks, such as sprains, strains and [...]
Written by Dr Heather Davies-Strickleton, Senior Analytical Scientist Despite its name, ringworm is not caused by worms, it’s caused by fungi called dermatophytes that can infect the skin and cause a ring-shaped rash. This [...]
The significance of fungal infection is often neglected in society. However, fungal infections affect more than a billion people, resulting in approximately 11.5 million life-threatening infections and more than 1.5 million deaths annually.1 The antifungals, used to treat fungal infections, are a diverse group [...]
Onychomycosis (fungal nail infection) and tinea pedis (athlete’s foot), are some of the most common forms of fungal infection in adults and are often the first things that spring to mind when thinking of fungal infection. However, many other forms of fungal [...]
Fungal ‘superbug’ drug-resistant Candida auris has been identified by the Centres for Disease Control and Prevention (CDC) as a ‘serious threat to global health’ following a startling increase in the number of infection cases that do not respond to treatment over recent years. Candida is most notably associated [...]
As the World Health Organization focuses on what universal health coverage means in 2019, we explore the global challenges and opportunities in the control of fungal infection. Although we often think of fungal infection [...]
